Scientists at the University of Michigan have made a significant discovery in the field of colon cancer treatment.
Their research suggests that a low-protein diet could play a crucial role in enhancing the effectiveness of existing cancer therapies.
The study revolves around a key regulator of cancer growth called mTORC1, which uses nutritional signals to influence cell growth and multiplication. mTORC1 is particularly active in cancers with certain mutations, often leading to resistance against standard treatments.
What the researchers found is that a diet low in protein can disrupt the nutrient signaling pathway that activates mTORC1. Specifically, reducing two key amino acids appears to modify these signals through a complex called GATOR.
Previous efforts to tackle mTORC1 have focused on inhibiting its cancer-promoting signals. However, these inhibitors often come with significant side effects. Additionally, when patients stop taking these inhibitors, the cancer frequently returns.
This new approach of using a low-protein diet to block the nutrient pathway offers an alternative method to shut down mTORC1.
The researchers verified their findings both in cells and in mice, observing that limiting amino acids halted cancer growth and increased cell death.
Furthermore, tissue biopsies from patients with colon cancer showed that high levels of mTORC1 activity correlated with increased resistance to chemotherapy and poorer outcomes. This discovery opens up the possibility of tailoring treatments for patients based on this marker.
However, the researchers emphasize that a low-protein diet shouldn’t be seen as a standalone treatment but rather as a complementary approach alongside other therapies like chemotherapy.
One challenge with this dietary strategy is that cancer patients often suffer from muscle weakness and weight loss. A low-protein diet could exacerbate these issues.
Therefore, more research is needed to fine-tune this approach, possibly finding a therapeutic window to limit amino acids without causing harm to the patient.
Additionally, the team plans to further explore how these pathways contribute to treatment resistance.
This study, led by Yatrik M. Shah and published in Gastroenterology, marks an important step in understanding how dietary changes can impact cancer treatment and opens new avenues for personalized cancer therapy.
For those interested in cancer research, this study adds to the growing body of knowledge about how diet and nutrition can influence cancer risk and treatment outcomes.
It’s part of a broader discussion on managing cancer through a combination of dietary modifications, lifestyle changes, and medical treatments.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Scientific Diet. All rights reserved.
